QuidelOrtho Corp QDEL
News
VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.
QuidelOrtho to Participate in Upcoming Investor Conferences
QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
QuidelOrtho Reports Second Quarter 2024 Financial Results
Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600
QuidelOrtho to Report Second Quarter 2024 Financial Results
QuidelOrtho's stock loses about a third of its value after earnings miss